Depression Prevention Programs: A Pilot Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Depressive Symptoms
- Sponsor
- Oregon Research Institute
- Enrollment
- 91
- Locations
- 1
- Primary Endpoint
- Change from baseline Depressive Disorder Diagnostic using the Kiddie Schedule for Affective Disorders and Schizophrenia at 6 weeks, 3 months and 6 months
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of this study is to compare the effectiveness of two depression prevention programs and a control brochure for college students. Participants may experience reductions in depressive symptoms and prevention of future depression.
Investigators
Eligibility Criteria
Inclusion Criteria
- •current student at the University of Oregon
- •subthreshold symptoms of depression, as indicated by a CES-D depression screener score of 20 or greater
Exclusion Criteria
- •current diagnosis of major depression
- •acute suicidal ideation requiring immediate mental health treatment
Outcomes
Primary Outcomes
Change from baseline Depressive Disorder Diagnostic using the Kiddie Schedule for Affective Disorders and Schizophrenia at 6 weeks, 3 months and 6 months
Time Frame: Measured at baseline, 6 weeks, 3 months and 6 months
Evaluate change (if any) by using the Kiddie Schedule for Affective Disorders and Schizophrenia at the 6 week, 3 month and 6 month marks.
Difference in future onset of Major Depressive Disorder using the Kiddie Schedule for Affective Disorders and Schizophrenia
Time Frame: Measured at baseline, 6 weeks, 3 months and 6 months.
Evaluate difference (if any) in the future onset of Major Depressive Disorder at 3 months and 6 months.
Difference in attendance in Change Ahead vs Blues Program groups using group leader notes
Time Frame: Measured at each group therapy session (6 weeks in total).
Evaluate difference (if any) in attendance in Change Ahead vs Blues Program group therapies by using group leader notes.
Secondary Outcomes
- Negative life events(Measured at baseline)
- Emotions(Measured at baseline, weeks 2,4 and 6.)
- Positive and negative thoughts(Measured at baseline, weeks 2,4 and 6.)
- Assessments using writing samples(Measured at baseline and 6 weeks)
- Depression and anxiety symptoms using the PHQ-9(Measured at baseline, 6 weeks, 3 months and 6 months)
- Social adjustment in school, work, peer, spare time, and family domains(Measured at baseline, 6 weeks, 3 months and 6 months)
- Depression and anxiety symptoms using the GAD-7(Measured at baseline, 6 weeks, 3 months and 6 months)
- Health care utilization(Measured at baseline, 6 weeks, 3 months and 6 months)
- Negative automatic thoughts(Measured at baseline, 6 weeks, 3 months and 6 months)
- Substance use(Measured at baseline (in intake screener), 6 weeks, 3 months and 6 months)
- Activity level(Measured at baseline, weeks 2,4 and 6.)
- Negative attributional style(Measured at baseline, 6 weeks, 3 months and 6 months)